Showing results (431-440 of 481) with videos related to
Sort By:
Pageof 49
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.Neurobiology of Disease|October 21, 2019
Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathologyA Joly-Amado, H Davtyan, K Serraneau, et al.Gynecologic Oncology|July 15, 2014
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancerIgnace Vergote, Russell J Schilder, Charles H Pippitt, et al.The Journal of Infectious Diseases|April 1, 2011
Smallpox vaccine safety is dependent on T cells and not B cellsShari N Gordon, Valentina Cecchinato, Vibeke Andresen, et al.Nature Medicine|January 14, 1998
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenesL Holcomb, M N Gordon, E McGowan, et al.Gynecologic Oncology Reports|October 25, 2022
Incidence and predictors of toxicity in the management of vulvar squamous cell carcinoma treated with radiation therapyNeal S McCall, Tony Y Eng, Joseph W Shelton, et al.Nature Communications|July 12, 2016
Automated circuit fabrication and direct characterization of carbon nanotube vibrationsG Zeevi, M Shlafman, T Tabachnik, et al.Gastroenterology|October 9, 2007
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac diseaseAntonio Di Sabatino, Karen M Pickard, John N Gordon, et al.The Journal of Clinical Investigation|February 15, 2011
Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cellsJeffrey M Milush, Kiran D Mir, Vasudha Sundaravaradan, et al.Gynecologic Oncology|October 8, 2011
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancerAlan N Gordon, Michael Teneriello, Mike F Janicek, et al.Pageof 49